We are live on
!
Find out more
AA
Altrafin AG Portfolio holdings
AUM
$255M
1-Year Est. Return
21.67%
This Fund
S&P 500
This Quarter
Est. Return
+3.28%
1 Year Est. Return
+21.67%
3 Year Est. Return
+97.62%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$315M
AUM Growth
+$10.3K
(+0%)
Cap. Flow
-$5.61M
Cap. Flow
% of AUM
-1.78%
Top 10 Holdings %
Top 10 Hldgs %
63.65%
Holding
51
New
3
Increased
18
Reduced
15
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$6.22M |
| 2 |
UnitedHealth
UNH
|
+$5.51M |
| 3 |
Uber
UBER
|
+$5.06M |
| 4 |
Netflix
NFLX
|
+$1.56M |
| 5 |
Amazon
AMZN
|
+$1.08M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$9.19M |
| 2 |
NVIDIA
NVDA
|
+$6.76M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$3.73M |
| 4 |
Booking.com
BKNG
|
+$3.49M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$3.36M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.1% |
| 2 | Financials | 21.23% |
| 3 | Communication Services | 16.98% |
| 4 | Consumer Discretionary | 9.59% |
| 5 | Healthcare | 6.55% |
Similar funds
TPF
MAM
CWA
TFG
PCM
VIPI
SWM
SFC
Altrafin AG's Q4 2025 Portfolio in Review
As of Q4 2025, Altrafin AG held 51 positions worth $315M, up 0% from $315M the previous quarter. Its ten largest holdings account for 64% of the portfolio.
Altrafin AG's Q4 2025 filing shows 3 new, 18 increased, 15 reduced and 5 closed positions. The largest sale was PayPal, an estimated $9.19M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 40% a quarter earlier, followed by Financials and Communication Services.
- Altrafin AG added most to Mastercard in Q4 2025, an estimated $6.22M increase.
- Altrafin AG's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $6.76M.
- Altrafin AG fully exited PayPal in Q4 2025, selling an estimated $9.19M.
- Altrafin AG's ten largest holdings make up 64% of its $315M portfolio in Q4 2025.
- Altrafin AG opened 3 new positions and closed 5 in Q4 2025.
- Altrafin AG's portfolio value rose 0% quarter-over-quarter to $315M.
Based on Altrafin AG's 13F filing for Q4 2025, filed 13 Feb 2026.